Reticulocyte hemoglobin content shows how much hemoglobin is inside your newest red blood cells. These young cells, called reticulocytes, leave the bone marrow only a short time before becoming mature red blood cells. Because they are so new, their hemoglobin level gives an early look at whether your bone marrow has enough usable iron to make healthy red blood cells right now. This can make CHr or RET-He helpful when iron deficiency is suspected before hemoglobin, MCV, or ferritin gives a clear answer.
A low RET-He usually means iron is not reaching developing red blood cells well enough. That may happen from low iron stores, blood loss, poor absorption, pregnancy, heavy menstrual bleeding, chronic kidney disease, inflammation, or recent treatment changes. The test is usually interpreted with a complete blood count, ferritin, transferrin saturation, and sometimes other anemia markers, because RET-He alone cannot identify the cause.
- RET-He or CHr measures hemoglobin in reticulocytes, the newest red blood cells released from bone marrow.
- A low result usually points to iron-restricted red blood cell production, often from iron deficiency or inflammation-related iron trapping.
- Adult reference ranges often sit near 29–38 pg, but many diagnostic cutoffs for iron deficiency fall around 28–31 pg depending on the lab and analyzer.
- RET-He can change within days after iron therapy, while hemoglobin often takes weeks to rise clearly.
- A normal RET-He makes active iron-restricted erythropoiesis less likely, but it does not rule out early iron store depletion in every person.
- Recent transfusion, thalassemia trait, B12 or folate deficiency, kidney disease, inflammation, and pregnancy can change how results should be read.
Table of Contents
- What Reticulocyte Hemoglobin Measures
- Normal Range and Cutoffs
- Low RET-He Results
- Normal or High RET-He Results
- How RET-He Compares With Other Iron Tests
- Anemia Patterns and Common Causes
- Testing, Preparation, and Follow-Up
- When Results Need Medical Attention
What Reticulocyte Hemoglobin Measures
Reticulocyte hemoglobin content measures the amount of hemoglobin packed into reticulocytes. Hemoglobin is the iron-containing protein that lets red blood cells carry oxygen. Reticulocytes are newly made red blood cells that have recently left the bone marrow. They usually mature into full red blood cells within about one to two days.
This timing makes the marker useful. Mature red blood cells live for about 120 days, so many standard red blood cell measurements reflect a mix of older and newer cells. RET-He focuses on the newest cells, so it reflects iron availability for red blood cell production over the past few days.
The test may appear on a lab report under different names:
- RET-He, meaning reticulocyte hemoglobin equivalent
- CHr, meaning reticulocyte hemoglobin content
- Retic-Hb, reticulocyte hemoglobin, or reticulocyte hemoglobin concentration
These names are closely related, but they are not always perfectly interchangeable. Different hematology analyzers calculate the measurement in slightly different ways. RET-He is commonly associated with Sysmex analyzers, while CHr has historically been associated with Siemens/ADVIA systems. Both aim to answer the same clinical question: are new red blood cells receiving enough usable iron?
Doctors often order RET-He with a complete blood count and a reticulocyte count. The CBC shows hemoglobin, hematocrit, MCV, MCH, RDW, red blood cell count, white blood cells, and platelets. The reticulocyte count shows how actively the marrow is making new red blood cells. RET-He adds a different layer: whether those newly produced cells contain enough hemoglobin.
This is especially helpful because iron deficiency develops in stages. First, iron stores fall. Then the supply of usable iron to the marrow becomes limited. Later, red blood cells become smaller and paler, and hemoglobin falls. RET-He can become abnormal during the “iron-restricted erythropoiesis” stage, when red blood cell production is already short of iron but anemia may not yet look severe.
Normal Range and Cutoffs
RET-He and CHr are usually reported in picograms, written as pg. A picogram is one trillionth of a gram. Some laboratories may also report related units, but pg is the most common format.
There is no single worldwide normal range. The reference interval depends on the analyzer, lab method, age group, population, and clinical setting. Many adult lab ranges are roughly around 29–38 pg, and some large clinical laboratories use an adult reference interval near 30.0–37.6 pg. Some Sysmex-based materials list adult RET-He reference ranges around 29.3–35.4 pg. Your own lab’s reference interval should be used first.
Diagnostic cutoffs are a separate issue. A lab’s “normal range” describes values seen in a reference population. A clinical cutoff is a decision point that helps estimate whether iron deficiency or iron-restricted red blood cell production is likely. Studies and guidelines have used different cutoffs, often between about 28 and 31 pg.
| Result pattern | Common meaning | Important caution |
|---|---|---|
| About 29–38 pg in many adults | Often within the expected range for hemoglobin in new red blood cells | Use the range printed on your report because labs differ |
| Below about 28–31 pg | May suggest reduced iron supply to developing red blood cells | Cutoffs vary by analyzer, age, pregnancy status, and illness |
| Below about 25–26 pg | Often more concerning for significant iron-restricted erythropoiesis or a microcytic condition | Thalassemia trait can also lower RET-He |
| Rising after iron treatment | Often suggests early marrow response to iron | Hemoglobin may still take several weeks to rise |
In chronic kidney disease, hemodialysis, and erythropoiesis-stimulating agent treatment, clinicians may use different decision points. Some kidney guidelines and studies discuss CHr values below about 29–31 pg as evidence of iron-restricted erythropoiesis, especially when ferritin and transferrin saturation are hard to interpret.
Children, infants, pregnancy, chronic inflammation, kidney disease, and hemoglobin disorders need different interpretation. A value that looks mildly low in one setting may carry more weight in another. A value that appears normal can also be misleading if a recent transfusion or mixed anemia has changed the red blood cell population.
Low RET-He Results
A low RET-He means the newest red blood cells contain less hemoglobin than expected. In plain terms, the bone marrow is producing new red cells, but those cells are not getting enough usable iron to build normal hemoglobin.
Iron deficiency is the most common reason. The body may not have enough stored iron, or it may be losing iron faster than it can replace it. Common sources include heavy menstrual bleeding, gastrointestinal bleeding, frequent blood donation, pregnancy, recent childbirth, low iron intake, and reduced absorption from celiac disease, bariatric surgery, autoimmune gastritis, Helicobacter pylori infection, or long-term acid suppression in some people.
Low RET-He can also occur when iron is present in the body but not available to the marrow. This is called functional iron deficiency or iron-restricted erythropoiesis. It often appears with chronic inflammation, infection, cancer, chronic kidney disease, heart failure, autoimmune disease, or after surgery. In these states, the hormone hepcidin can rise and trap iron inside storage cells. Ferritin may look normal or high because ferritin rises with inflammation, yet the marrow may still be short of usable iron.
A low result should be interpreted with symptoms and other labs. Symptoms that fit iron deficiency include fatigue, weakness, shortness of breath with exertion, dizziness, headaches, cold intolerance, restless legs, brittle nails, hair shedding, pale skin, and cravings for ice or non-food substances. Some people have low iron markers before they feel obvious symptoms.
Low RET-He does not prove that iron deficiency is the only problem. Thalassemia trait, some hemoglobin disorders, lead exposure, sideroblastic anemia, copper deficiency, and mixed nutritional deficiencies can also produce small or poorly hemoglobinized red cells. If MCV is low, the pattern may overlap with low MCV, low MCH, and high RDW.
Low RET-He before anemia appears
RET-He can fall before hemoglobin drops below the anemia range. This can happen because reticulocytes are new, while hemoglobin reflects the whole circulating red cell population. Early iron restriction may affect today’s new cells even while many older red blood cells still carry normal hemoglobin.
This pattern can matter in people at higher risk of iron deficiency, such as menstruating adults with heavy periods, endurance athletes, frequent blood donors, pregnant people, young children, and people with inflammatory bowel disease. A low RET-He with normal hemoglobin may still deserve follow-up if symptoms or risk factors are present.
Low RET-He during treatment
If RET-He stays low after iron therapy begins, several explanations are possible. The dose may be too low, the iron may not be taken consistently, side effects may be limiting use, absorption may be poor, blood loss may be continuing, inflammation may be blocking iron use, or the diagnosis may be incomplete. In some cases, oral iron is not enough and intravenous iron is considered, especially when anemia is significant, absorption is poor, or rapid correction is needed.
Normal or High RET-He Results
A normal RET-He generally means the bone marrow has enough usable iron to make hemoglobin in new red blood cells at the time of testing. This makes active iron-restricted red cell production less likely. It can be reassuring when ferritin is difficult to interpret because of inflammation.
A normal result does not rule out every form of iron deficiency. Iron stores can be low before marrow supply becomes limited. A person may have low or borderline ferritin with normal RET-He if the marrow is still receiving enough iron for the moment. This can happen early in deficiency or after recent iron intake. It may also happen if the cutoff used by a study does not match the lab’s analyzer.
A high RET-He is less commonly the focus of clinical concern. It usually means new red blood cells contain plenty of hemoglobin. It may be seen after successful iron therapy, after recovery from iron-restricted erythropoiesis, or in settings where red cell production has improved. It does not usually mean iron overload by itself. Iron overload is assessed with iron studies such as ferritin, transferrin saturation, and sometimes liver imaging or genetic testing, depending on the case.
Normal or high RET-He may appear with anemia from causes that do not primarily restrict iron delivery to the marrow. Examples include acute bleeding before iron stores have fallen, hemolysis, kidney-related low erythropoietin, B12 or folate deficiency, bone marrow disorders, chronic disease patterns with mixed mechanisms, or dilutional anemia in pregnancy. In these cases, hemoglobin may be low while RET-He remains normal.
Recent blood transfusion can make RET-He harder to interpret because the measured blood sample contains donor red cells and the patient’s own cells. Recent IV iron, oral iron, erythropoiesis-stimulating agents, chemotherapy recovery, and major bleeding can also change results quickly.
How RET-He Compares With Other Iron Tests
RET-He is not a replacement for a full iron evaluation. It answers a narrower but useful question: are new red blood cells getting enough iron to make hemoglobin? Other iron tests answer different questions.
Ferritin estimates stored iron. It is often the best single test for iron stores when inflammation is absent. Low ferritin strongly supports iron deficiency. The challenge is that ferritin can rise during inflammation, infection, liver disease, cancer, kidney disease, and metabolic illness. A person can have normal or high ferritin and still have limited usable iron for red blood cell production.
Transferrin saturation, or TSAT, estimates how much circulating iron is bound to transferrin. Low transferrin saturation can support iron deficiency or functional iron restriction. Serum iron and TSAT can vary during the day and can shift with recent iron intake, inflammation, illness, and fasting status.
TIBC and transferrin describe iron-binding capacity. High TIBC often fits iron deficiency because the body makes more transferrin to search for iron. Low TIBC can appear with inflammation, liver disease, malnutrition, and chronic illness. For a broader view, many clinicians order an iron panel rather than relying on one marker.
Soluble transferrin receptor, or sTfR, can help when iron deficiency and inflammation overlap. It tends to rise when cells need more iron and is less affected by inflammation than ferritin. It is not available everywhere and may be interpreted with the sTfR-ferritin index in some settings. A soluble transferrin receptor test can be especially useful when ferritin is confusing.
| Marker | What it mainly shows | Strength | Common limitation |
|---|---|---|---|
| RET-He or CHr | Iron available to new red blood cells | Changes early and can respond within days | Cutoffs differ; thalassemia and mixed anemia can confuse results |
| Ferritin | Iron stores | Low values strongly support iron deficiency | Can rise with inflammation or liver disease |
| TSAT | Circulating iron supply | Helpful in CKD and inflammatory states | Can fluctuate with illness, timing, and recent intake |
| TIBC or transferrin | Iron-binding capacity | High values often fit iron deficiency | Low values may reflect inflammation or liver disease |
| MCV and MCH | Size and hemoglobin content of mature red cells | Useful for anemia classification | May change later than RET-He |
| Hemoglobin | Severity of anemia | Shows oxygen-carrying impact | Does not identify the cause |
RET-He is often most useful when combined with ferritin and TSAT. For example, low RET-He, low ferritin, and low TSAT strongly support iron deficiency affecting red blood cell production. Low RET-He with normal or high ferritin and low TSAT suggests functional iron restriction, especially if C-reactive protein, chronic kidney disease, or inflammation is present. Normal RET-He with low ferritin may suggest depleted stores that have not yet limited marrow iron supply.
Anemia Patterns and Common Causes
RET-He fits into anemia interpretation by showing whether iron delivery to new red cells is part of the problem. It becomes more useful when paired with hemoglobin, MCV, RDW, reticulocyte count, ferritin, TSAT, kidney markers, inflammatory markers, and clinical history.
A low RET-He with low hemoglobin often points toward iron deficiency anemia or iron-restricted anemia. If ferritin is low, absolute iron deficiency becomes likely. If ferritin is normal or high but TSAT is low, inflammation or chronic kidney disease may be blocking iron use. Kidney disease can also reduce erythropoietin, the hormone that tells the marrow to make red blood cells.
A low RET-He with normal hemoglobin may show early iron restriction. This pattern can appear before classic anemia. It may also appear after blood loss, during pregnancy, or in athletes with high iron demands.
A low RET-He with a high or normal red blood cell count and very low MCV can suggest thalassemia trait rather than ordinary iron deficiency. In thalassemia trait, the body makes smaller red cells because of inherited hemoglobin production differences. Iron should not be taken long term unless iron deficiency is also proven.
A normal RET-He with low hemoglobin can point away from iron-restricted erythropoiesis and toward other anemia causes. These may include B12 deficiency, folate deficiency, kidney disease, hemolysis, acute blood loss, chronic disease, bone marrow suppression, or medication effects. A low hemoglobin result always needs cause-based interpretation rather than treatment based on iron alone.
Common causes of low RET-He
Low RET-He may be linked to:
- Heavy menstrual bleeding or uterine fibroids
- Gastrointestinal blood loss from ulcers, polyps, cancer, inflammatory bowel disease, hemorrhoids, or frequent NSAID use
- Pregnancy, postpartum recovery, or rapid growth in children
- Low dietary iron intake, especially without enough heme iron or fortified foods
- Poor absorption from celiac disease, bariatric surgery, autoimmune gastritis, or chronic digestive disease
- Chronic kidney disease, especially with dialysis or erythropoietin-stimulating drugs
- Chronic inflammation, infection, autoimmune disease, cancer, or recent surgery
- Thalassemia trait or other inherited microcytic anemia
- Lead exposure or sideroblastic anemia in selected cases
The cause matters because iron deficiency is not a final diagnosis. It is a clue. In adults, especially men and postmenopausal women, iron deficiency anemia often needs evaluation for blood loss unless there is an obvious explanation. In menstruating adults, heavy periods are common, but digestive causes can still occur.
Testing, Preparation, and Follow-Up
RET-He is measured from a standard blood sample, usually drawn from a vein in the arm. It often requires no special preparation. Fasting is usually not needed for RET-He itself, but your clinician may order iron studies at the same time. Some iron markers, especially serum iron and TSAT, can be influenced by recent iron intake and timing, so follow the instructions given for the full lab order.
Tell your clinician about iron supplements, prenatal vitamins, recent IV iron, recent transfusion, erythropoiesis-stimulating agents, heavy bleeding, pregnancy, kidney disease, inflammatory disease, and recent infection. These details can change the interpretation.
If RET-He is low, follow-up usually includes a broader anemia and iron review. Common next steps include:
- Review CBC markers, including hemoglobin, MCV, MCH, RDW, and platelet count.
- Check ferritin, serum iron, TIBC or transferrin, and TSAT.
- Consider C-reactive protein or another inflammation marker if ferritin may be falsely high.
- Review diet, menstrual history, pregnancy status, blood donation, digestive symptoms, and medications.
- Consider B12, folate, kidney function, thyroid testing, hemolysis labs, or hemoglobin electrophoresis when the pattern does not fit simple iron deficiency.
- Identify the source of iron loss or poor absorption before assuming supplements alone are enough.
RET-He can be useful for monitoring treatment response. Because reticulocytes are young, RET-He may rise within several days after effective iron therapy. Hemoglobin often rises more slowly, commonly over two to four weeks, and full repletion of iron stores may take longer. Ferritin may take months to rebuild, depending on the dose, cause, and ongoing losses.
Do not judge treatment success by one number alone. A rising RET-He with stable hemoglobin may still be an early good sign. A normalizing hemoglobin with persistently low ferritin may mean anemia improved but iron stores are not yet replenished. A low RET-He despite treatment suggests the plan needs review.
Oral iron works best when the dose, timing, and tolerability are realistic. Some people absorb iron better with alternate-day dosing than daily high-dose schedules, and many have fewer stomach side effects with lower or less frequent dosing. Calcium, tea, coffee, and some medications can reduce absorption when taken close to iron. Vitamin C may help absorption for some people, but it is not always necessary. Intravenous iron may be used when oral iron fails, is not tolerated, is poorly absorbed, or when faster correction is medically important.
When Results Need Medical Attention
A low RET-He is usually not an emergency by itself. The urgency depends on hemoglobin level, symptoms, bleeding, pregnancy status, age, heart disease, and how quickly anemia developed.
Seek prompt medical care if anemia symptoms are severe or sudden. Warning signs include chest pain, fainting, shortness of breath at rest, rapid heartbeat, black or bloody stools, vomiting blood, severe weakness, confusion, or heavy bleeding that does not slow. People with heart disease, advanced kidney disease, cancer, pregnancy, or very low hemoglobin need closer medical guidance.
Children, pregnant people, and older adults should not ignore a low RET-He or iron deficiency pattern. Children need iron for brain development and growth. Pregnancy increases iron demand and untreated anemia can affect both parent and baby. In older adults, new iron deficiency anemia may signal gastrointestinal blood loss even without obvious digestive symptoms.
Iron supplements should not be used blindly for months without understanding the cause. Too much iron can be harmful, and unnecessary iron can be risky in people with iron overload disorders, repeated transfusions, some liver diseases, or anemia that is not caused by iron deficiency. RET-He can help guide the discussion, but ferritin, TSAT, CBC results, medical history, and sometimes further testing decide the safest plan.
The most useful interpretation is pattern-based. Low RET-He says the newest red blood cells are short on hemoglobin. The next step is to find out why: low stores, ongoing blood loss, poor absorption, inflammation, kidney disease, thalassemia trait, or a mixed anemia. Once the cause is clear, RET-He can also help show whether treatment is reaching the bone marrow.
References
- The effect of reticulocyte hemoglobin content on the diagnosis of iron deficiency anemia: A meta-analysis study 2022 (Systematic Review)
- Using Reticulocyte Hemoglobin Equivalent as a Marker for Iron Deficiency and Responsiveness to Iron Therapy 2021 (Study)
- Reticulocyte Hemoglobin-Equivalent Potentially Detects, Diagnoses and Discriminates between Stages of Iron Deficiency with High Sensitivity and Specificity 2022 (Study)
- British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults 2021 (Guideline)
- UK kidney association clinical practice guideline: update of anaemia of chronic kidney disease 2025 (Guideline)
- WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations 2020 (Guideline)
Disclaimer
RET-He or CHr results should be interpreted by a qualified clinician together with your CBC, iron studies, symptoms, medical history, and medications. A low result can support iron-restricted red blood cell production, but it does not identify the cause by itself. Seek medical care promptly for severe anemia symptoms, signs of bleeding, pregnancy-related concerns, or rapidly worsening results.
